Holen Sie sich die Stockscreener-App
2.05
2.26%
0.06
Handel nachbörslich:
2.05
Schlusskurs vom Vortag:
$1.99
Offen:
$1.98
24-Stunden-Volumen:
1.75M
Relative Volume:
1.36
Marktkapitalisierung:
$174.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-59.69M
KGV:
-1.4748
EPS:
-1.39
Netto-Cashflow:
$-46.54M
1W Leistung:
-2.16%
1M Leistung:
+3.83%
6M Leistung:
+144.71%
1J Leistung:
+37.50%
1-Tages-Spanne:
$1.97
$2.09
1-Wochen-Bereich:
$1.96
$2.14
52-Wochen-Spanne:
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Firmenname
Milestone Pharmaceuticals Inc
Sektor
Branche
Telefon
(514) 336-0444
Adresse
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Vergleichen Sie MIST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
2.05 | 169.14M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-06-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-04-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-29 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-07-24 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-25 | Herabstufung | Jefferies | Buy → Hold |
| 2020-03-24 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-03-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-03 | Eingeleitet | Cowen | Outperform |
| 2019-06-03 | Eingeleitet | Jefferies | Buy |
| 2019-06-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten
Will Milestone Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Milestone Pharmaceuticals Inc.’s volatility index tracking explainedWeekly Stock Analysis & Safe Capital Investment Plans - newser.com
Milestone Pharmaceuticals Inc Stock Analysis and ForecastTrading Volume Trends & Big Data Market Reports - earlytimes.in
Is Milestone Pharmaceuticals Inc. forming a bottoming baseWeekly Volume Report & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-10-10 05:09:19 - newser.com
Brokerages Set Milestone Pharmaceuticals Inc. (NASDAQ:MIST) PT at $4.50 - Defense World
Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025 - The Manila Times
Milestone Pharmaceuticals to Present Etripamil Data at AHA Scientific Sessions 2025 - Quiver Quantitative
Published on: 2025-10-09 06:06:14 - newser.com
Is December The Breakthrough Moment For MIST? - RTTNews
Will Milestone Pharmaceuticals Inc. stock reach Wall Street targetsQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Visualizing Milestone Pharmaceuticals Inc. stock with heatmaps2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
Is Milestone Pharmaceuticals Inc. stock a safe investment in uncertain marketsJuly 2025 Reactions & Technical Entry and Exit Alerts - newser.com
Milestone Pharmaceuticals: Playing The Long Ball In Cardiovascular Treatment (NASDAQ:MIST) - Seeking Alpha
How hedge fund analytics apply to Milestone Pharmaceuticals Inc. stockTrade Risk Summary & Community Shared Stock Ideas - newser.com
Chart based analysis of Milestone Pharmaceuticals Inc. trendsGDP Growth & Weekly Market Pulse Updates - newser.com
Milestone Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Is Milestone Pharmaceuticals Inc. forming a reversal patternIPO Watch & Risk Managed Investment Signals - newser.com
Candlestick signals on Milestone Pharmaceuticals Inc. stock todaySwing Trade & AI Based Buy/Sell Signal Reports - newser.com
How Milestone Pharmaceuticals Inc. stock trades during market volatility - newser.com
Will Milestone Pharmaceuticals Inc. stock reach all time highs in 2025Market Rally & Scalable Portfolio Growth Methods - newser.com
What analysts say about Milestone Pharmaceuticals Inc stockMarket Insider Reports & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Published on: 2025-09-29 11:35:53 - newser.com
Real time scanner hits for Milestone Pharmaceuticals Inc. explainedBear Alert & Daily Price Action Insights - newser.com
Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):